Alleviation of side effects induced by irinotecan hydrochloride (CPT-11) in rats by intravenous infusion

被引：0
|
作者：
Akinobu Kurita
Shoichi Kado
Norimasa Kaneda
Masaharu Onoue
Shusuke Hashimoto
Teruo Yokokura
机构：
[1] Yakult Central Institute for Microbiological Research,
来源：
Cancer Chemotherapy and Pharmacology | 2003年 / 52卷
关键词：
Irinotecan hydrochloride; CPT-11; SN-38; Myelosuppression; Acute diarrhea; Delayed-onset diarrhea;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：349 / 360
页数：11
相关论文
共 50 条
  • [31] The current status of irinotecan (CPT-11) in the United States
    Rothenberg, ML
    CAMPTOTHECINS: FROM DISCOVERY TO THE PATIENT, 1996, 803 : 272 - 281
  • [32] Involvement of beta-glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats
    Takasuna, K
    Hagiwara, T
    Hirohashi, M
    Kato, M
    Nomura, M
    Nagai, E
    Yokoi, T
    Kamataki, T
    CANCER RESEARCH, 1996, 56 (16) : 3752 - 3757
  • [33] Future directions for clinical research with CPT-11 (irinotecan)
    VonHoff, D
    EUROPEAN JOURNAL OF CANCER, 1996, 32A : S9 - S12
  • [34] Successful salvage treatment with irinotecan (CPT-11) of recurrent malignant lymphoma in an aged patient; and CPT-11 pharmacokinetics
    Yamauchi, T
    Amaya, N
    Yoshio, N
    Yoshida, A
    Tsutani, H
    Ueda, T
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1999, 69 (03) : 165 - 169
  • [35] Intestinal alkalization as a possible preventive mechanism in irinotecan (CPT-11)-induced diarrhea
    Ikegami, T
    Ha, L
    Arimori, K
    Latham, P
    Kobayashi, K
    Ceryak, S
    Matsuzaki, Y
    Bouscarel, B
    CANCER RESEARCH, 2002, 62 (01) : 179 - 187
  • [36] THE ROLE OF INTESTINAL AND HEPATIC GLUCURONIDATION IN CHEMOTHERAPY INDUCED TOXICITY BY IRINOTECAN (CPT-11)
    Chen, Shujuan
    Yueh, Mei-Fei
    Barbier, Olivier
    Bigo, Cyril
    Wang, Kepeng
    Karin, Michael
    Nguyen, Nghia
    Tukey, Robert H.
    DRUG METABOLISM REVIEWS, 2014, 45 : 20 - 21
  • [37] Molecular predictor of irinotecan (CPT-11) efficacy.
    Rhodes, KE
    Vallböhmer, D
    Zhang, W
    Yang, DY
    Yun, J
    Press, O
    Gordon, M
    Iqbal, S
    Lenz, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 261S - 261S
  • [38] Irinotecan (CPT-11) Treatment Induces Mild Gonadotoxicity
    Levi, Mattan
    Ben-Aharon, Irit
    Shalgi, Ruth
    FRONTIERS IN REPRODUCTIVE HEALTH, 2022, 4
  • [39] Combination chemotherapy with irinotecan hydrochloride (CPT-11) and mitomycin C in platinum-refractory ovarian cancer
    Aoki, Y
    Kurata, H
    Watanabe, M
    Fujita, K
    Tanaka, K
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (05): : 461 - 464
  • [40] Irinotecan hydrochloride (CPT-11) and mitomycin C as the first line chemotherapy for ovarian clear cell adenocarcinorna
    Nishino, K
    Aoki, Y
    Amikura, T
    Obata, H
    Sekine, M
    Yahata, T
    Fujita, K
    Tanaka, K
    GYNECOLOGIC ONCOLOGY, 2005, 97 (03) : 893 - 897
12345